Roger Barker (Former)
61 – 70 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
- Contribution to journal › Article
-
Mark
Imaging nigrostriatal circuitry with 11C-PE2I PET and Neuromelanin-sensitive MR in Parkinson’s disease
- Contribution to conference › Abstract
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
- Contribution to conference › Abstract
-
Mark
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
- Contribution to journal › Article
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
- Contribution to journal › Article
-
Mark
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
- Contribution to journal › Article
-
Mark
A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease
- Contribution to journal › Article
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
- Contribution to journal › Article
